S.R.I.W. logo

S.R.I.W.

Europe, Liege, Belgium, Liège

Description

S.R.I.W. (Société Régionale d'Investissement de Wallonie) stands as the primary regional investment company for Wallonia, Belgium, playing a pivotal role in the economic development of the region. Established with the mission to support entrepreneurs and businesses, S.R.I.W. acts as a strategic financial partner, providing capital and expertise to foster the creation, growth, and transformation of companies. Its long-term vision is deeply rooted in strengthening the Walloon industrial fabric and promoting innovation across various sectors, thereby contributing significantly to regional prosperity and employment.

The investment strategy of S.R.I.W. is broad and adaptable, reflecting its mandate to support the diverse economic landscape of Wallonia. The firm invests across a wide spectrum of stages, from early-stage startups requiring seed capital to established enterprises seeking growth financing or undergoing restructuring. While sector-agnostic in principle, S.R.I.W. often prioritizes industries deemed strategic for the region, including life sciences, digital technologies, advanced manufacturing, logistics, and green initiatives. They frequently engage in co-investment alongside private equity funds, banks, and other financial institutions, leveraging their capital to attract further investment into Walloon companies.

S.R.I.W.'s financial commitments are substantial and tailored to the specific needs of each project. While initial equity investments can start from approximately €250,000 for early-stage ventures, the firm is capable of deploying several million euros for larger growth-stage companies or significant industrial projects. For instance, in 2022, S.R.I.W. invested a total of €164 million across 115 projects, underscoring its significant impact on the regional economy. This robust financial capacity allows S.R.I.W. to be a cornerstone investor, providing crucial capital that might otherwise be difficult for Walloon companies to secure. Their involvement extends beyond mere capital provision, often including strategic guidance and network access.

In essence, S.R.I.W. is more than just an investor; it is a key enabler of economic dynamism in Wallonia. By offering flexible financing solutions and acting as a committed, long-term partner, it helps drive innovation, create sustainable jobs, and enhance the competitiveness of the region's businesses on both national and international stages. Its consistent investment activity reinforces its position as an indispensable institution for the Walloon entrepreneurial ecosystem.

Investor Profile

S.R.I.W. has backed more than 60 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 8% of its total and boasts 15 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Belgium, United States, France.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Typical check size: $270K – $8.1M.

Stage Focus

  • Series B (32%)
  • Series A (28%)
  • Series Unknown (18%)
  • Series C (7%)
  • Seed (5%)
  • Series D (3%)
  • Undisclosed (2%)
  • Series E (2%)
  • Secondary Market (2%)
  • Private Equity (2%)

Country Focus

  • Belgium (83%)
  • United States (8%)
  • France (3%)
  • The Netherlands (3%)
  • Spain (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Manufacturing
  • Software
  • Information Technology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does S.R.I.W. frequently co-invest with?

XAnge
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 10
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 14
Newton Biocapital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 4
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 7
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 9
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 7
Capricorn Partners
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 5
Inventures SA
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 4
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 20

Which angels does S.R.I.W. often collaborate with?

MK
Europe, Nord-Pas-de-Calais, France, Lille
Shared Deals: 1
MV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
FV
Europe, Brabant Wallon, Belgium, Ottignies
Shared Deals: 1
DD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
Shared Deals: 1
TE
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1
ER
Europe, Ile-de-France, France, Paris
Shared Deals: 1
GL
North America, California, United States, San Francisco
Shared Deals: 1
OK
Europe, Niedersachsen, Germany, Hanover
Shared Deals: 1
PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 2

What are some of recent deals done by S.R.I.W.?

Santero Therapeutics

Charleroi, Hainaut, Belgium

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

BiotechnologyHealth CareTherapeutics
Series AJun 8, 2023
Amount Raised: $8,625,644
Intressa Vascular

Isnes, Namur, Belgium

Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.

Health CareMedical
UndisclosedOct 25, 2022
Amount Raised: $11,954,585
Univercells

Gosselies, Hainaut, Belgium

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

BiotechnologyHealth CareManufacturing
Series DOct 19, 2022
Amount Raised: $42,968,876
BOTALYS

Ghislenghien, Hainaut, Belgium

We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.

AgTechBiotechnologyDietary SupplementsHealth CareNutraceuticalWellness
Series BOct 4, 2022
Amount Raised: $6,639,040
I-care Group

Mons, Hainaut, Belgium

I-care Group changes the way the world performs through predictive and prescriptive maintenance.

Artificial Intelligence (AI)Big DataIndustrial AutomationIndustrial ManufacturingInternet of ThingsMachine LearningPredictive Analytics
Series CSep 30, 2022
Amount Raised: $49,009,998
Aerospacelab

Mont-saint-guibert, Brabant Wallon, Belgium

Aerospacelab is a company aiming at tackling some of the most challenging problems with a completely different paradigm.

Aerospace
Series BFeb 16, 2022
Amount Raised: $45,491,300
EyeD Pharma

Liège, Liege, Belgium

EyeD Pharma is a pharmaceutical company dedicated to the development of innovative drug products in ophthalmology.

BiopharmaBiotechnologyPharmaceutical
Series UnknownDec 24, 2021
Amount Raised: $50,951,260
PDC*line Pharma

La Tronche, Rhone-Alpes, France

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells.

BiotechnologyHealth CareTherapeutics
Series BDec 6, 2021
Amount Raised: $13,314,903
EsoBiotec

Mont-saint-guibert, Brabant Wallon, Belgium

soBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.

Biotechnology
SeedSep 30, 2021
Amount Raised: $3,472,351
Sortlist

Wavre, Brabant Wallon, Belgium

Sortlist reinvents the way businesses find marketing and communication agencies.

AdvertisingCommunications InfrastructureInformation TechnologyInternetMarketingPeer to Peer
Series BSep 15, 2021
Amount Raised: $13,001,457